|
Hematologic Malignancies Demystified - Atlanta A Critical Appraisal of Data from 2018
Explore the options in hematology and hematologic malignancies with this live meeting. Stay informed on new data with established agents and gain insight into the use of novel agents in your practice. Expert faculty will focus on updates from recent congresses and the latest clinically relevant data. |
|
|
Hematologic Malignancies Demystified - Houston A Critical Appraisal of Data from 2018
Explore the options in hematology and hematologic malignancies with this live meeting. Stay informed on new data with established agents and gain insight into the use of novel agents in your practice. Expert faculty will focus on updates from recent congresses and the latest clinically relevant data. |
|
Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors
STATEMENT OF NEED
Carcinoid syndrome refers to a constellation of symptoms caused by the systemic release of humoral factors such as polypeptides, biogenic amines, and prostaglandins, mostly from well-differentiated neuroendocrine tumors. Patients frequently experience flushing, abdominal cramps, bronchospasms, hypotension, and diarrhea, which lead to impaired quality of life and daily functioning. In addition, complications such as carcinoid heart disease and mesenteric and/or retroperiton... |
|
ASCCP2019 Annual Meeting
ASCCP2019 Annual Scientific Meeting on Anogenital and HPV-Related Diseases will feature a variety of topics including:
Barriers to Care (transgender, homeless, incarcerated, mentally ill, as well as age and obesity)
Patient-Centered Counseling Techniques for Discussing Risk and Disease State Concepts
Research Ethics and At-Risk Populations
Cervical Cancer Screening Guidelines – U.S. and Beyond
ASCCP Colposcopy Standards with Cases
Risk-Based Assessment and Management
As well as spec... |
|
|
Current Challenges and New Opportunities in Follicular Lymphoma
STATEMENT OF NEED
Of the estimated 74,680 new cases of non-Hodgkin lymphoma each year in the United States, approximately 35% are follicular lymphoma (FL), an indolent, difficult-to-treat B-cell malignancy. Most patients are diagnosed at an average age of 65 years. Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrences with availab... |
|
|
Applying Advances with Checkpoint Inhibitors in Thoracic Oncology
Lung cancer is a leading cause of cancer-related deaths worldwide. It is estimated that 222,500 new cases of lung cancer will occur in the United States in 2018, resulting in 155,870 deaths. Mesothelioma, a cancer that can develop in the lining of the lungs, is commonly caused by exposure to asbestos and is associated with a poor prognosis. Advances in lung cancer treatment, including the introduction of immune checkpoint inhibitors, are increasing the number of patients who receive treatment ... |
|
|
Breast Ultrasound with Tom Stavros: Hot Topics in Advanced Screening and Diagnosis
Welcome to San Antonio and Hot Topics in Advanced Screening and Diagnosis. This course will emphasize a new classification system on breast cancer and will focus on “non”-mass ultrasound findings, an analysis of causes of false negative BI-RADS 3 classifications, and new ways of classifying breast nodules that can help objectively assign BI-RADS 4 subcategories and improve ultrasound’s ability to serve as a bio-marker. Dr. Stavros will lead interactive case readings with an audience re... |
|
|
Self-Care Specialist (SCS) Unit 4: Women's Health
Women are generally not too shy in asking questions in the "Feminine Hygiene" aisle. They are very proactive about their health and given a private area, they will specifically tell you what symptoms they are having. This activity is an overview to women's most frequent health issues, including vaginal infections, urinary tract infections and menstrual maladies. We will discuss the number of sexual lubricants that are available and select the right ones be it for a woman wanting to conceive or... |
|
|
Payment Models and Practice Changes: Meeting Requirements of OCM & MACRA
Recent legislation and policy has fast-tracked the shift of healthcare payment from volume- to value-based reimbursement under the Medicare Access and CHIP Reauthorization Act (MACRA) for oncology care. Today, oncologists have the option to be reimbursed for Medicare patients under the CMS Oncology Care Model (OCM), an alternative payment model spanning a 6-month chemotherapy episode-of-care. This activity will provide insight into the program’s structure and challenges. It will also review ... |
|
|
Integrating Therapeutic Advances to Improve Current Practices in Myeloma Patient Care
Improving outcomes for patients with multiple myeloma requires building on the foundation of current therapies with new agents and combinations, recognizing the nature of each individual patient’s disease, and providing a personalized approach to treatment. This activity uses evidence-based presentations and case study vignettes to present the latest information on selecting the most appropriate therapy based on patient profile, clinical evidence, and assessment of risk-versus-benefit.
Le... |
|
|
Evidence-based Updates in Non-Hodgkin’s Lymphoma
Significant advances in treatment with novel agents for B-cell non-Hodgkin’s lymphoma (NHL) have improved patient outcomes and survival. However, many patients are at high-risk of relapse, meriting a precision approach to reduce the rate of recurrence and improve outcomes. The identification of molecular subtypes, the persistence of clinical challenges, and the anticipated emergence of clinical data necessitate a collaborative treatment approach to ensure individualized care for patients wit... |
|
|
Integrating Immunotherapy for NSCLC
The emergence of checkpoint inhibitors (CTLA4, PD1, PD-L1) has reawakened an interest in immunotherapy to treat various malignancies. New agents have rapidly been approved for use in melanoma, bladder cancer, renal cell, lung cancer, and other malignancies. These agents have a unique toxicity profile requiring careful clinical assessment, rapid intervention, and aggressive management of side effects.
This activity will provide a general overview of immunotherapy in cancer treatment, with a ... |
|
|
Improving Colorectal Cancer Prevention: Latest Advances to Improve Adenoma Detection Rates
Colorectal cancer (CRC) is the third most common type of cancer worldwide and second deadliest form of cancer in the United States. Current estimates suggest that up to 25% of adenomas are missed with current colonoscopy technologies, primarily due to poor visualization in folds and other difficult-to-detect areas. Technological advances in recent years have improved detection rates. This CME activity will review appropriate screening and prevention efforts for the early detection of patients ... |
|
|
Checkpoint Inhibitors in Gastrointestinal Tumors: The Latest Evidence on Safety, Efficacy, and Biomarkers
The genomes of cancers deficient in mismatch repair (MMR) contain extremely high numbers of somatic mutations. Analysis of recent clinical studies have demonstrated that colorectal cancers with mismatch repair deficiency (dMMR) and other advanced dMMR cancers are sensitive to immune checkpoint blockade with PD-1 antibodies, and that mutational burden correlates with treatment response. These findings have led to the recent approval of two immune checkpoint inhibitors for the treatment of micro... |
|
|
Navigating New Options to Improve Outcomes in Multiple Myeloma
As new combinations and classes of agents emerge for the treatment of multiple myeloma (MM), community-based treatment teams require clarity on the optimal integration of recently approved and emerging agents into the relapsed/refractory landscape for MM. While high-dose chemotherapy is not appropriate for all patients, multiple options have emerged that demonstrate a clinical benefit and require proper integration into the treatment paradigm. In addition, clinicians must meet requirements for... |
|
|
Targeted Therapy for Skin Malignancies: Basal Cell Carcinoma, Melanoma, and Merkel Cell
Patients may not always be offered the most appropriate single and combination targeted therapies that have been proven effective in clinical trials. Currently available clinical data have practice-changing implications for medical oncologists, dermatologists, and related specialists treating skin malignancies. To stay up to date with the latest data, evidence will be presented related to the role of BRAF inhibition, hedgehog signaling, and immunotherapy in the pathogenesis and treatment of ba... |
|
|
Updates in General Internal Medicine for Specialists 2019
Advances, Updates, Guidelines, and Best Practices in General Internal Medicine—Expressly for Specialists
In this special program, Harvard Medical School's leading clinical faculty, representing more than 30 fields of medicine, share updates and provide recommendations to ensure you are current with the recent advances in general internal medicine that impact the specialists—especially with clinical practice in relevant disciplines outside of your field of expertise.
Whether you are a psy... |
|
|
Advances in Breast Cancer Management 2019
This course will provide an overview of the most recent advances in the management of patients with early and advanced stage breast cancer. Topics include imaging, radiation therapy, brain metastases, genomic testing, systemic therapy and survivorship. The course is intended to provide practical, evidence-based information on clinically relevant issues for physicians and allied health personnel involved in patient care. The didactic format will provide significant opportunities for interaction... |
|
|
The Oncologist: The Challenges of Validating in Precision Medicine: The Case of ERCC1 Diagnostic Testing
Learning Objectives:
1. Describe the obstacles to the successful translation of predictive/prognostic molecular cancer biomarkers to the clinic.
2. Explain the importance of prospective design and good study reporting in predictive/prognostic cancer marker development.
3. Discuss the way poor study design and coordination can impede rapid biomarker validation in cancer.
Personalized medicine relies upon the successful identification and translation of predictive biomarkers. Unfortunately... |
|
|
The Oncologist: Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?—Time to Embrace a New Digit
Learning Objective:
1. Describe the ways in which adequate LN dissection improves long-term survival without compromising patient safety.
Background.
The present study assessed the impact of the retrieval of >25 lymph nodes (LNs) on the survival outcome of patients with advanced gastric cancer after curative‐intent gastrectomy.
Patients and Methods.
A total of 5,386 patients who had undergone curative gastrectomy for gastric cancer from 1994 to 2011 were enrolled. The clinicopatholo... |
|
|
Precision Medicine and Impact of Therapeutic Drug Levels
Much has been written recently about the need for genetic testing and biomarkers to identify specific targets within cancers, recognizing that there are many subclones and individual differences within the malignancies that arise in patients, even in those with morphologically similar cancers. Another important aspect of cancer treatment is the need to optimize the dose and schedule of administered therapies.
Pharmacogenomics has demonstrated that the bioavailability and half-lives of anti-ca... |
|
|
Targeting EGFR, T790M, ALK, and ROS1 in NSCLC
Oncology treatment teams are tasked with navigating through a steady increase in the number and complexity of molecular biomarkers that guide treatment decisions. FDA-approved companion tests have expanded testing options and provide uniformity of reporting, yet challenges in the clinical setting and the potential to negatively impact patient outcomes persist. As part of the continuum of care in oncology, there is an increasing demand for genomic testing to guide the course of treatment.
Misi... |
|
|
The Oncologist: The Impact of an Educational Program on Patient Practices for Safe Use, Storage, and Disposal of Opioids at a Comprehensive Cancer Center
Learning Objectives:
1. Describe the problem of opioid abuse as it relates to knowledge of patients regarding proper use, storage, and disposal of opioids.
2. Describe the process undergone by the outpatient supportive care clinic described in the article to implement an opioid education program in order to address gaps in patient knowledge.
Background.
Improper use, storage, and disposal of prescribed opioids can lead to diversion or accidental poisoning. Our previous study showed a lar... |
|
|
The Oncologist: A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer – Alliance (CALGB) 9581 and 89803
Learning Objectives:
1. Describe the association between tumor levels of thymidylate synthase and outcomes in patients with resected colon cancer treated with adjuvant therapy
2. Discuss the value of thymidylate synthase levels in predicting treatment benefits of 5-fluorouracil in patients with resected colon cancer
Purpose.
Tumor levels of thymidylate synthase (TS), a target of 5‐fluorouracil (5‐FU)‐based chemotherapy for colorectal cancer, have been studied as a predictive or pro... |
|
|
Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing Over the Past 3 Months
This educational activity will utilize a case study to discuss the diagnosis and management of a 35-year-old man who has a brown pigmented lesion that has been changing over the past 3 months.
|
|
|
Penn Radiology Oncologic Imaging: Optimizing Patient Care (Streaming Online & DVD-ROM)
Penn Radiology joins forces with its experts in Nuclear Medicine, Gastroenterology, Pulmonology, Radiation and Interventional Oncology to present this comprehensive review of Oncologic Imaging. Best practices and clinical correlates will be discussed, with two detailed sessions dedicated to CT screening for lung cancer. Credits for this program can be applied toward your Self Assessment CME Requirements for ABR Maintenance of Certification.
Topics: CT Screening for Lung Cancer, State of th... |
|
|
Penn Radiology Oncologic Imaging: Optimizing Patient Care
Meetings by Mail presents Penn Radiology Oncologic Imaging: Optimizing Patient Care. This comprehensive review of Oncologic Imaging features discussions regarding best practices and clinical correlates, with two detailed sessions dedicated to CT screening for lung cancer.
Other topics include: state of the art and emerging techniques, head and neck cancer, thoracic, GI and other abdominal Malignancies, neuroendocrine tumors, lymphoma, melanoma and MSK. Available in Online Streaming and DVD... |
|
|
4th Annual Ash 2018 Updates: Practice Changing Abstracts
Patients in medically underserved communities have limited access to subspecialty care. Community-based oncologists are well positioned to provide initial care for these patients, but often do not have the knowledge and confidence to manage difficult cases. According to the 2015 Community Health Needs Assessment, between 2006 and 2008, the City of Chicago experienced an annual average adjusted cancer mortality rate of 194.2 deaths per 100,000 individuals. Cancer mortality has decreased over th... |
|
|
Clinical and Multidisciplinary Hematology and Oncology 2019 : The 16th Annual Review
This course will include a comprehensive update and management strategies of issues in hematologic and oncologic malignancies presenting new disease classification, treatment, and challenging cases. Course topics will focus on hematologic diseases, solid tumors and overlap topics of supportive, ancillary and diagnostic care. The course offers challenging and interactive sessions on pertinent issues involved with the care of patients. |
|
|
NYU's Head to Toe Imaging: NYU School of Medicine Clinical Update
Topics covered by NYU's Head to Toe Imaging include:
Imaging of Pancreatic Adenocarcinoma, Inflammatory Bowel Disease, Renal Cell Carcinoma, Abdominal Trauma, Thyroid Ultrasound, Airway Disease, Coronary Artery Disease, Chest Imaging, Brain Tumor, Pediatric Abdomen. Pediatric Knee, Cruciate Ligaments, Posterior Shoulder Instability, Venous Thromboembolism and many others.
After viewing NYU's Head to Toe Imaging, you will be better able to:
• Evaluate and incorporate current imaging techni... |
|
|
Metastatic Breast Cancer
While mortality rates for breast cancer are decreasing, metastatic breast cancer (MBC) remains incurable. This session will review new treatment options based on molecular and genetic information, the level of evidence used to formulate practice guidelines, as well as updates from ASCO 2017. New agents, including PARP inhibitors for those with appropriate mutations, will also be discussed. Clinically-oriented guidelines on the management of MBC were developed by the European Society for Medica... |
|
|
Redefining Care for BRCA and Other Familial-associated Cancers
Advances in molecular genetics and testing have refined the diagnosis, treatment, and follow-up for patients with BRCA and other familial genetic syndromes. As women with germline BRCA1 and BRCA2 mutations are at an increased risk for developing high-grade serous ovarian cancer, there are implications for genetic testing, family counseling, radiologic screening, and pharmaceutical choices in the community setting. Molecular and genetic advances, such as novel PARP inhibitors, are altering the ... |
|
|
Rheumatic Immune-related Adverse Events: Multidisciplinary Perspectives on Recognition and Management
The introduction of immune checkpoint inhibitors has had a great impact on the field of oncology. However, these new therapies are associated with a spectrum of autoimmune and systemic inflammatory reactions known as immune-related adverse events (irAEs). Rheumatologists are likely to encounter a wide variety of irAEs as the use of immune checkpoint inhibitors expands in the treatment of several cancers. Thus, it is critical for rheumatologists to be aware of these complications to accurately ... |
|
|
Interventional Pulmonology in Cancer Patients
www.mdanderson.org/conferences |
|
|
Immune Checkpoint Inhibitors for Bladder Cancer: Practice Essential for Community Oncologists and Advanced Practice Providers
For many years, the mainstay of initial treatment for metastatic bladder cancer has been chemotherapy. However, immunotherapy with PD-1/PD-L1 checkpoint inhibitors is revolutionizing the treatment of bladder cancer. Currently, 5 checkpoint inhibitors are approved for patients who have failed prior platinum-based chemotherapy or are ineligible for cisplatin-based chemotherapy. In this CME activity, expert faculty will assess the clinical evidence regarding the efficacy, safety, and tolerability... |
|
|
Fact or Fiction? Sorting Out Common Misconceptions About Ulcerative Colitis to Improve Patient Care
It is well established that ulcerative colitis (UC) is a heterogeneous disease with symptoms that wane over time. The disease course for 50% of individuals is persistently active over time with worsening and relapsing symptoms and is associated with long-term anemia, colonic dysfunction, and increased risk for colorectal cancer. Evidence indicates that treating the inflammation to achieve improvement in endoscopic appearance of the mucosa early in the course of UC is effective for current flar... |
|
|
Use of Oncology Quality Measures Where Do We Go from Here?
The new CMMI guidelines for physician reimbursement for patient care require some demonstration of quality and value in care delivery. Certain quality programs are available to oncologists (such as PQRS, QOPI, etc.). These assessments of quality require demonstration that specific guidelines are measured and followed within acceptable compliance targets. This session will address how these measures are developed and applied for use in the new payment models. |
|
|
Achieving Precision Care in Gastrointestinal Cancers
Treatment selection is largely dependent on the goals of therapy; however, sequencing of standard therapies with newly approved therapies as patients’ progress is a key factor in improving quality of care. The recent approval of new agents and advances in biomarker detection have supported the individualization of treatment and subsequent improvements in survival for patients with gastrointestinal cancers.
As new agents are expected to enter the treatment paradigm in 2017, clinicians will r... |
|
|
Practical Thoracic Imaging 2019
PRACTICAL THORACIC IMAGING course is designed as a comprehensive imaging review of diseases that affect the chest. Experienced faculty has been selected to cover the subject material that emphasizes their approach to solving clinically relevant problems involving the chest. Review of traditional imaging as well as the benefits and caveats of newer imaging techniques will be presented. Ample time for questions and discussion will be provided. There will be practical case presentations to enco... |
|
|
Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer
The recent inclusion of targeted biologic agents in guideline recommendations has provided oncologists with more treatment options and patients with the potential for improved outcomes. However, these additional options also increase the complexity of treatment selections and appropriate sequencing of treatments for patients with gastric and gastroesophageal (GEJ) cancers.
Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer will guide community clinicians... |
|
|
Advances in Colorectal Cancer – From Screening to Innovative Care
Colorectal cancer is the #2 cause of cancer death in North America. While we successfully screen for colorectal cancer, many gaps in evidence-based treatment remain. Current practitioners have questions about the role of circulating tumor DNA in the diagnosis and management of early to advanced colorectal cancer; the role of endoscopic microsurgery in the management of colon cancer; and when full oncologic surgery is required to deliver the most appropriate care for colon cancer. For patients ... |
|
|
Ace the Case: A 48-Year-Old Woman Confused About a Diagnosis of Leukemia
This “Ace the Case” activity will utilize a case study to discuss the assessment and management of a 48-year-old woman with a myeloproliferative disorder. Accurately assess the appropriate treatment option(s) for this patient for CME credits.
|
|
|
The Oncologist: Aspirin is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction
Learning Objectives:
1. Describe the relationship between severe thrombocytopenia and mortality in patients with AMI and hematologic malignancies.
2. Discuss the effect of aspirin therapy on patients with AMI and severe thrombocytopenia.
Background.
Patients with hematologic malignancies are at risk for severe thrombocytopenia (sTP). The risk and benefit of aspirin are not known in thrombocytopenic cancer patients experiencing acute myocardial infarction (AMI).
Materials and Methods.
... |
|
|
Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Patients with radioactive iodine-refractory thyroid cancer (RAIR-DTC) have poor prognoses and, until recently, there were no effective targeted systemic therapies available for RAIR-DTC. Targeted therapies sorafenib and lenvatinib have been approved by the FDA for treating RAIR-DTC in the last 5 years. Along with these approved therapies, other targeted therapies, such as cabozantinib and vandetanib, which were approved earlier in the decade by the FDA for treating medullary thyroid cancer, ar... |
|
|
DSM-5 and ICD-10: Uses, Challenges, and Documentation
Explore DSM-5 Coding issues, uses and misuses in the world of ICD-10. Dr. Peck will define the clinical dilemmas in the use of DSM-5 or ICD-10 and the important changes Psychologists need to know in certain clinical diagnoses.
Examine clinical documentation improvement efforts in transitioning to ICD-10. MHMD Memorial Hermann’s journey to improve documentation and coding.
At the conclusion of the activity, attendees will be able to:
Explain the correlation of DSM-5 and ICD coding as... |
|
|
Breast Imaging 2019
This course blends the newest innovations in breast imaging with time-honored traditional breast imaging modalities and procedures. Special attention will be given to Tomosynthesis and Breast MR, as well as Whole Breast Ultrasound. The contentious issues of Breast Density Legislation and Screening Guidelines will also be addressed.
An interactive screening workshop in which the participants can evaluate 25 digital screening cases WITH TOMOSYNTHESIS at the workstation will be available in th... |
|
|
Quality Management and Compliance in the Pharmaceutical and Related Industries
Who Should Attend?
This intensive course will benefit those who need to understand the responsibilities and functions of the Quality Unit in a pharmaceutical firm and how the quality organization impacts all areas of operations and works as a team to help assure the quality of the products and compliance to regulations within in the pharmaceutical manufacturing arenas and related products. This material is particularly suitable for chemists, pharmacists, engineers and administrators working i... |
|
|
Optimizing Patient Outcomes in Castration-Resistant Prostate Cancer: Moving Urologists From Knowledge to Action
Evan Ya-Wen Yu, MD, provides his insights into the evolving management of patients with castration-resistant prostate cancer (CRPC) and the implications of the genomic landscape on CRPC. Since clinical trial evidence does not clearly inform sequencing strategies, Dr. Yu weaves his insight into this conundrum using 3 cases, with suggestions to help the urologist individualize treatment.
CONTENT AREAS
• National Comprehensive Cancer Network guidelines on prostate cancer
• Clinical tria... |
|
|
Lung Cancer Imaging: World Class CME and Oakstone Clinical Update
Topics covered by Lung Cancer Imaging include:
Lung Cancer Screening, Lung Nodule Classification, Repeat Annual Screens, Lung Cancer Diagnosis, Smoking Related Diffuse Lung Diseases, Imaging the Adenocarcinoma Spectrum, Lung Cancer Treatment, Imaging the Post-Surgical Lung Cancer Patient and many others.
Lung Cancer Imaging covers best practices in interpreting CT scans obtained for lung cancer screening, staging, and treatment follow-up for those who may be actively involved in lung cancer ... |
|
|
Obstetrics and Gynecology 2019
New Diagnosis and Treatment Updates in Clinical Obstetrics, Minimally Invasive Gynecologic Surgery, Urogynecology, Gynecologic Oncology, Reproductive Endocrinology, and Infertility
This special update on diagnosis and treatment of reproductive health conditions in women, designed and presented by Harvard Medical School’s leading faculty and master clinicians, ensures you are current with the latest advances in obstetrics and gynecology. One of the highest-rated Harvard Medical School CME ... |
|